IN2015DN03978A - - Google Patents

Download PDF

Info

Publication number
IN2015DN03978A
IN2015DN03978A IN3978DEN2015A IN2015DN03978A IN 2015DN03978 A IN2015DN03978 A IN 2015DN03978A IN 3978DEN2015 A IN3978DEN2015 A IN 3978DEN2015A IN 2015DN03978 A IN2015DN03978 A IN 2015DN03978A
Authority
IN
India
Prior art keywords
composition
present
compound
tricyclic indole
indole compound
Prior art date
Application number
Other languages
English (en)
Inventor
Sondre Nilsen
Srinath Balaji Aralikatti Prahladachar Balaji
Umamaheshwar P Mokkapati
Mohamed Afsal Mohammed Kadavilpparampu
Original Assignee
Ge Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1300647.3A external-priority patent/GB201300647D0/en
Application filed by Ge Healthcare Ltd filed Critical Ge Healthcare Ltd
Priority to IN3978DEN2015 priority Critical patent/IN2015DN03978A/en
Publication of IN2015DN03978A publication Critical patent/IN2015DN03978A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • C07D209/88Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
IN3978DEN2015 2012-11-30 2013-11-28 IN2015DN03978A (enrdf_load_stackoverflow)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN3978DEN2015 IN2015DN03978A (enrdf_load_stackoverflow) 2012-11-30 2013-11-28

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN3689DE2012 2012-11-30
GBGB1300647.3A GB201300647D0 (en) 2013-01-15 2013-01-15 Crystallization
IN3978DEN2015 IN2015DN03978A (enrdf_load_stackoverflow) 2012-11-30 2013-11-28
PCT/EP2013/074986 WO2014083113A1 (en) 2012-11-30 2013-11-28 Crystallization process of tricyclic indole derivatives

Publications (1)

Publication Number Publication Date
IN2015DN03978A true IN2015DN03978A (enrdf_load_stackoverflow) 2015-10-02

Family

ID=54266915

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3978DEN2015 IN2015DN03978A (enrdf_load_stackoverflow) 2012-11-30 2013-11-28

Country Status (12)

Country Link
US (1) US10709798B2 (enrdf_load_stackoverflow)
EP (1) EP2943195A1 (enrdf_load_stackoverflow)
JP (1) JP6280560B2 (enrdf_load_stackoverflow)
KR (1) KR20150088802A (enrdf_load_stackoverflow)
CN (2) CN104837489A (enrdf_load_stackoverflow)
AU (1) AU2013351152A1 (enrdf_load_stackoverflow)
BR (1) BR112015012138A2 (enrdf_load_stackoverflow)
CA (1) CA2892485A1 (enrdf_load_stackoverflow)
IN (1) IN2015DN03978A (enrdf_load_stackoverflow)
MX (1) MX2015006871A (enrdf_load_stackoverflow)
RU (1) RU2015118217A (enrdf_load_stackoverflow)
WO (1) WO2014083113A1 (enrdf_load_stackoverflow)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2015118217A (ru) 2012-11-30 2017-01-11 ДжиИ ХЕЛТКЕР ЛИМИТЕД Способ кристаллизации трициклических индольных производных
US20160144477A1 (en) * 2014-11-21 2016-05-26 Diane Scott Coated compressive subpad for chemical mechanical polishing

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177440B1 (en) * 1996-10-30 2001-01-23 Eli Lilly And Company Substituted tricyclics
JP2001522884A (ja) 1997-11-14 2001-11-20 イーライ・リリー・アンド・カンパニー アルツハイマー病の処置方法
DZ2769A1 (fr) 1998-04-17 2003-12-01 Lilly Co Eli Composés tricycliques substitués.
ES2252497T3 (es) 2001-08-09 2006-05-16 Eli Lilly And Company Derivados ciclohept(b)indol como inhibidores de spla2.
EP1423366A1 (en) 2001-08-09 2004-06-02 Eli Lilly And Company Cyclopenta b ! indole derivatives as spla2 inhibitors
GB0905328D0 (en) * 2009-03-27 2009-05-13 Ge Healthcare Ltd Indole derivatives
CA2792394C (en) 2010-03-26 2018-04-24 Radha Achanath Tricyclic indole derivatives as pbr ligands
GB201016038D0 (en) 2010-09-24 2010-11-10 Ge Healthcare Ltd In vivo imaging method
GB201016411D0 (en) 2010-09-30 2010-11-10 Ge Healthcare Ltd In vivo imaging method for cancer
GB201021263D0 (en) 2010-12-15 2011-01-26 Ge Healthcare Ltd Solid phase extraction method
US9220795B2 (en) * 2011-09-22 2015-12-29 Ge Healthcare Limited Indole derivatives
RU2015118217A (ru) 2012-11-30 2017-01-11 ДжиИ ХЕЛТКЕР ЛИМИТЕД Способ кристаллизации трициклических индольных производных

Also Published As

Publication number Publication date
JP2016507477A (ja) 2016-03-10
US10709798B2 (en) 2020-07-14
KR20150088802A (ko) 2015-08-03
CN104837489A (zh) 2015-08-12
MX2015006871A (es) 2015-09-16
WO2014083113A1 (en) 2014-06-05
RU2015118217A (ru) 2017-01-11
CN111362863A (zh) 2020-07-03
US20150335766A1 (en) 2015-11-26
EP2943195A1 (en) 2015-11-18
BR112015012138A2 (pt) 2017-07-11
AU2013351152A1 (en) 2015-05-21
JP6280560B2 (ja) 2018-02-14
CA2892485A1 (en) 2014-06-05

Similar Documents

Publication Publication Date Title
IN2012MN02591A (enrdf_load_stackoverflow)
IN2014MN00988A (enrdf_load_stackoverflow)
IN2015DN01156A (enrdf_load_stackoverflow)
IN2014MN00948A (enrdf_load_stackoverflow)
MY188960A (en) Cyclic boronic acid ester derivatives and therapeutic uses thereof
IN2014MN00986A (enrdf_load_stackoverflow)
MD20150091A2 (ro) Compuşi antivirali
IN2014MN02598A (enrdf_load_stackoverflow)
IN2014MN02049A (enrdf_load_stackoverflow)
IN2014MN00987A (enrdf_load_stackoverflow)
TW201240990A (en) Antiviral compounds
UA115558C2 (uk) Алкілпіримідинові похідні для лікування вірусних інфекцій та подальших захворювань
NZ743274A (en) Substituted tricyclic compounds as fgfr inhibitors
GB2511685A (en) Muscarinic m1 receptor agonists
PH12015501452A1 (en) Novel quinolone derivatives
WO2014028600A3 (en) 3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
IN2015DN01119A (enrdf_load_stackoverflow)
PH12014501514A1 (en) New azetidine derivatives, pharmaceutical compositions and uses thereof
PH12015501609A1 (en) Phenicol antibacterials
MX2019012939A (es) Formulaciones que contienen linaclotida para administracion oral.
MX2013004759A (es) Compuestos de oxima como agentes de elevacion de colesterol de lipoproteina de alta densidad (hdl).
IN2014MN02056A (enrdf_load_stackoverflow)
GB2489382A (en) Azetidine derivatives useful for the treatment of metabolic and inflammatory diseases
IN2013DN02555A (enrdf_load_stackoverflow)
IN2014DN03010A (enrdf_load_stackoverflow)